# Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis

> **NCT02330146** · PHASE1,PHASE2 · TERMINATED · sponsor: **RepliCel Life Sciences, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Tendinosis
- Tendinopathy

## Interventions

- **DRUG:** RCT-01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02330146
- **Lead sponsor:** RepliCel Life Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2016-12
- **Final completion:** 2017-06
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** * slower than anticipated rate of enrollment
* need to obtain safety and efficacy data in a timely manner
* pending expiry of manufacturing materials/reagents
- **Last updated:** 2017-09-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330146, "Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02330146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*